Dr. Thomas Gene Caligiuri Jr., MD

Dr. Caligiuri practices at U.S. Renal Care North Richland Hills Dialysis in Fort Worth, Texas.

Dr. Caligiuri's NPI, 1407318470, was assigned on April 1, 2019. Dr. Caligiuri graduated from Texas A&M College of Medicine - Bryan in 2019. Dr. Caligiuri holds Texas license V2028.

Dr. Caligiuri's primary practice is U.S. Renal Care North Richland Hills Dialysis, at 1902 Windsor Pl, Fort Worth, TX 76110 in Tarrant County. The practice phone is (817) 485-8700.

Dr. Caligiuri's primary practice is U.S. Renal Care North Richland Hills Dialysis in Fort Worth, Texas. Dr. Caligiuri is also affiliated with John Peter Smith Hospital. The medical group on file is Acclaim Health. Dmand AI also links Dr. Caligiuri to 4 more hospitals, 2 group practices and clinics, 1 dialysis center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Caligiuri practices, 8 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Caligiuri's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Caligiuri is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Caligiuri's licenses on file in 2 states: Texas and Louisiana.

CMS data shows 289 Medicare services from Dr. Caligiuri across 4 procedure codes in 2024, for 92 Medicare patients. Medicare paid $20,831 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 92 Medicare patients who saw Dr. Caligiuri in 2024. The largest group is 65 to 74, with 31 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 29% are also on Medicaid. Their average risk score is 4.41, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Caligiuri's median patient age at 66, with 51% women.

In 2024, Dr. Caligiuri wrote 279 Medicare Part D claims for 68 patients. 91% of them were for generic drugs. CMS names the drug for 164 of them, across 7 drugs with 11 or more claims each, at $1,755 in total drug cost. In 2023, CMS named 119 claims across 6 drugs.

Dr. Caligiuri accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 128 general payments to Dr. Caligiuri from 27 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 95% of the total. AstraZeneca Pharmaceuticals LP paid the most, $631.

Dr. Caligiuri graduated from Texas A&M College of Medicine - Bryan in 2019.

Dr. Caligiuri is in network with 18 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.